Sublocade Will No Longer Be Available in Australia After December 2026
Contrôle des drogues
02 Juil 2026
If you are on the Long-Acting Injectable Buprenorphine (LAIB) product Sublocade, you may have heard from your prescriber that by the time 2027 arrives, you will need to make a change to your opioid treatment.
Indivior, the pharmaceutical company that produces this monthly opioid treatment, has made a financial decision to withdraw Sublocade from several regions worldwide. The list includes Australia, where profit is down due to the high costs of support services, local packaging and transport against the relatively low number of people on prescription. As of 11 December 2026, the last shipment of the injectable will have reached Australia, with enough of the drug available for all those on Sublocade to receive a final dose to take them into the new year.
AIVL has been assured that the focus is on making the transition from Sublocade less stressful for everyone involved and to ensure the best outcome possible for our community members affected by the changes.
The majority of people on the program are likely to choose to transition to the one other LAIB product on the Australian market. Buvidal, from pharmaceutical company Camurus, is a very similar drug and is appropriate and safe to transition to from Sublocade.
AIVL CEO John Gobeil said: “For most people, moving to another medication that works in the same way and is also dosed monthly as an injectable might be the best option. But we all have a right to choose how we would like to manage changes in our treatment and some people may decide to start withdrawing from the program with the right support in place. Others who were happy on a product with daily doses may decide they would prefer to return to Suboxone or methadone and should be appropriately assisted to do so”.
John added this important advice: “Whichever way you want to go, please make sure that you access all the information necessary to support your decision-making process by talking to your prescriber and talking to your peers. That might include finding people in our community who have made the sort of change you’re thinking about and asking how the process was for them.”
As a final word, he wanted anyone deciding to move off the program to think about their vulnerability to overdose. “If using opiates is on the cards after a period on the treatment program, please take very good care of yourself. Start low, go slow and don’t use alone and make sure to have naloxone with you.”
The best way to stay in control of the process and move towards the changes confidently is to talk to your prescriber as soon as possible, so they can offer us the best care. All medical professionals prescribing and dosing Sublocade across clinics, medical centres, private practices and pharmacies will be supported by health departments, professional organisations, such as the RACGP and RACP and the relevant pharmaceutical companies.
While there are differences between the two products, with Buvidal not offering the same high doses, lasting power or bioaccumulation offered by Sublocade, the goal is to provide a comparable experience. Efforts have begun to provide prescribers with sufficient information and advice to adequately review and calculate new dosing arrangements.
If you are currently on Sublocade, the sooner you meet with your prescriber to work out the details of your transition, the sooner your mind will be put at rest. Questions you should consider asking include whether there will be any changes in the way you will experience your monthly injection, if you will feel any different on a new medication and how you might compensate for that. You may also want to know what to do if you feel that the new dose is not holding you or if you have side effects including headaches, nausea, insomnia or excessive sweating.
Deputy CEO Ele Morrison, a peer with personal experience of the opioid treatment program, had this advice to support people affected by Indivior’s decision: “If you are on Sublocade or know someone on the medication, you can call your local Drug User Organisation or AIVL to talk to a peer who understands the issues and respects your rights. Giving you clear, evidence-based information and advice to support your healthcare choices is one of the main reasons we exist.”
Ele also reminded community members that “if the process feels harder than it should be or you aren’t sure what to do, think about taking someone you trust to support you or talk to the peers at your local Drug User Organisation. They might be able to give you some tips around representing yourself or even advocate for you directly.”
We are here for you, Stay connected and stay safe.
| État ou territoire | Organisation des consommateurs de drogues |
|---|---|
| Territoire de la capitale australienne | Alliance de Canberra pour la minimisation des risques et la défense des droits (CAHMA) : (02) 6253 3643 |
| Nouvelle-Galles du Sud | NUAA’s Peerline: 1800 644 413 |
| Territoire du Nord | NTAHC: (08) 8944 7777 |
| Queensland | QuIVAA’s PeerQnect: 1800 175 889 |
| Australie du Sud | SA Harm Reduction Peer Services (SAhrps): 1800 437 222 ou (08) 83628443 |
| Tasmanie | Tasmanian Users and Health Support League (TUHSL): 02 5110 000 |
| Victoria | Harm Reduction Victoria (HRVic)/Service de médiation pour la défense de la pharmacothérapie (PAMS) : 1800 443 844 |
| Australie occidentale | Peer Based Harm Reduction Western Australian (PBHR WA): (08) 9325 8387 |

Arts et culture
10 Juil 2026
PACE (Peer Arts Collective Exhibition)

Arts et culture
10 Juil 2026
PACE (Peer Arts Collective Exhibition)
Êtes-vous un consommateur de drogues ? Exprimez-vous votre créativité à travers la peinture, la photographie, les installations, le street art, les poèmes ou les chansons ? Si tel est le cas, PACE (Peer Arts Collective Exhibition) vous invite à participer à un projet qui célèbre la créativité, la connexion et le pouvoir de l'expression.

Contrôle des drogues
02 Juil 2026
Sublocade Will No Longer Be Available in Australia After December 2026
People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.

Contrôle des drogues
08 avril 2026
Les groupes de test de pilules réduits au silence par Meta et TikTok alors que les stocks de drogues toxiques prolifèrent
Les réseaux sociaux doivent cesser d'urgence de censurer les avertissements concernant les médicaments qui sauvent des vies. Plusieurs organisations, dont Pill Testing Australia, CanTEST et leur partenaire néo-zélandais Know Your Stuff NZ, ont vu leurs publications supprimées, leurs comptes suspendus et, dans certains cas, des pages entières et des comptes personnels définitivement effacés, après que des systèmes automatisés de modération de contenu ont signalé leurs alertes de santé publique comme faisant la promotion de la consommation de drogues.

